Breast cancer adjuvant therapy benefit can wax and wane over time, study finds

November 2, 2015

After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy and endocrine drugs to reduce the risk of the cancer returning. It’s been assumed that the treatment effects of these therapies remain constant over time, but a new study from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio suggests the opposite is true.

Childhood cancer and blood disorders patients, survivors invited to free college and career fair on Saturday, Nov. 7

November 2, 2015

Young patients and survivors age 14 and up, along with their parents and siblings, are invited to the Childhood Cancer & Blood Disorders College and Career Fair this weekend.

S.A. Express-News Book & Author Luncheon Thursday features five authors, benefits CTRC

October 20, 2015

The 23nd Annual San Antonio Express-News Book & Author Luncheon benefits the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio.

Cancer Therapy & Research Center studies to be presented at American Society for Radiation Oncology Oct. 18-21

October 16, 2015

Research projects focus on improving treatment benefit while sparing normal tissues; CTRC volunteer to be honored.

Gene therapy doubles survival in recurrent glioblastoma

October 2, 2015

An experimental gene therapy essentially doubled the overall survival of patients with recurrent glioblastoma compared to the current standard of care, according to a study by the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio.

Researcher to discuss new brain cancer therapy’s effectiveness

October 1, 2015

Hear about promising results of an experimental gene therapy to treat the brain cancer killer glioblastoma.